Needle-Free myeloma monitoring: blood test and MRI show promise

This study explored whether a simple blood test (liquid biopsy) and a whole-body MRI can detect leftover cancer cells in people with multiple myeloma, potentially replacing the need for a bone marrow biopsy. Researchers enrolled 36 adults with newly diagnosed or previously treated myeloma. The goal was to see how accurate these non-invasive methods are at finding minimal residual disease (MRD). If proven effective, this approach could make monitoring the disease much easier and less painful for patients.